false
OasisLMS
Login
Catalog
Best Practice Case Studies
Case 117 Asset 2 Recommendations for Athletes with ...
Case 117 Asset 2 Recommendations for Athletes with Cardiac Channelopathies
Back to course
Pdf Summary
This AHA/ACC scientific statement addresses competitive sports participation for athletes with cardiac channelopathies, genetically mediated electrical disorders that can cause syncope, seizures, or sudden cardiac arrest despite a structurally normal heart. Major conditions include long-QT syndrome (LQTS), catecholaminergic polymorphic ventricular tachycardia (CPVT), Brugada syndrome (BrS), early repolarization syndrome, short-QT syndrome, and possibly idiopathic ventricular fibrillation.<br /><br />The statement emphasizes that these disorders are potentially lethal but often treatable, and that athletes should be evaluated by a highly experienced heart rhythm specialist or genetic cardiologist before return-to-play decisions are made. It notes that new genetic testing has revealed many concealed, genotype-positive/phenotype-negative individuals, but there is no strong evidence that such athletes experience events during sport solely because of a positive genetic test.<br /><br />Key precautions for affected athletes include avoiding QT-prolonging drugs, avoiding Brugada-triggering drugs, maintaining hydration and electrolytes, preventing or treating fever and heat illness, carrying a personal automated external defibrillator, and having an emergency action plan with team officials.<br /><br />The recommendations are:<br />- Symptomatic athletes with suspected or diagnosed channelopathy should be restricted from all competitive sports until fully evaluated, treated, informed, and symptom-free on therapy for at least 3 months.<br />- Asymptomatic athletes with concealed channelopathy may participate in all sports with precautions.<br />- Participation may be considered for certain athletes with manifest or previously symptomatic BrS, early repolarization syndrome, short-QT syndrome, or LQTS after treatment and 3 months without symptoms.<br />- CPVT is treated more restrictively: competitive sports are generally not recommended except class IA sports, due to higher exercise-triggered risk.<br /><br />Overall, the document supports individualized, specialist-guided decisions rather than blanket disqualification.
Meta Tag
Concept
Channelopathy
Concept
Long QT Syndrome
Concept
Catecholaminergic Polymorphic Ventricular Tachycardia
Concept
Sports Participation Restriction
Concept
Arrhythmia
Edition
4th Edition
Related Case
4th Edition, Case 117
Topic
Cardiac
Keywords
4th Edition
AHA/ACC
cardiac channelopathies
competitive sports
long-QT syndrome
catecholaminergic polymorphic ventricular tachycardia
Brugada syndrome
sudden cardiac arrest
genetic testing
heart rhythm specialist
return-to-play
4th Edition, Case 117
Cardiac
Channelopathy
Long QT Syndrome
Sports Participation Restriction
Arrhythmia
×
Please select your language
1
English